Sevil Zencir

812 total citations
32 papers, 579 citations indexed

About

Sevil Zencir is a scholar working on Molecular Biology, Organic Chemistry and Oncology. According to data from OpenAlex, Sevil Zencir has authored 32 papers receiving a total of 579 indexed citations (citations by other indexed papers that have themselves been cited), including 25 papers in Molecular Biology, 7 papers in Organic Chemistry and 6 papers in Oncology. Recurrent topics in Sevil Zencir's work include Cancer therapeutics and mechanisms (10 papers), Synthesis and biological activity (6 papers) and Cancer-related gene regulation (4 papers). Sevil Zencir is often cited by papers focused on Cancer therapeutics and mechanisms (10 papers), Synthesis and biological activity (6 papers) and Cancer-related gene regulation (4 papers). Sevil Zencir collaborates with scholars based in Türkiye, Hungary and Switzerland. Sevil Zencir's co-authors include Zeki Topçu, David Shore, Benjamin Albert, István Zupkó, Borbála Réthy, Hüseyin Bağcı, Vildan Caner, Sali̇h Çeti̇ner, Iuliia Boichenko and Ruud Hovius and has published in prestigious journals such as Nucleic Acids Research, Molecular Cell and PLoS ONE.

In The Last Decade

Sevil Zencir

30 papers receiving 566 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Sevil Zencir Türkiye 13 355 130 89 46 37 32 579
Kenneth D. Bromberg United States 14 746 2.1× 80 0.6× 163 1.8× 36 0.8× 67 1.8× 17 926
Yi Xiang China 14 570 1.6× 141 1.1× 47 0.5× 99 2.2× 116 3.1× 22 1.0k
Réna G. Deschesnes Canada 8 365 1.0× 55 0.4× 86 1.0× 20 0.4× 55 1.5× 9 535
Irene de Miguel Spain 16 368 1.0× 162 1.2× 66 0.7× 19 0.4× 31 0.8× 28 651
Daniela Baiocchi Italy 5 247 0.7× 43 0.3× 57 0.6× 22 0.5× 25 0.7× 7 338
Anna Mariana Australia 13 368 1.0× 80 0.6× 45 0.5× 21 0.5× 20 0.5× 16 677
Lautaro D. Álvarez Argentina 12 234 0.7× 108 0.8× 60 0.7× 44 1.0× 43 1.2× 32 512
R.‐J. Kuban Germany 10 161 0.5× 59 0.5× 70 0.8× 23 0.5× 32 0.9× 27 403
Becky Tu‐Sekine United States 13 338 1.0× 109 0.8× 63 0.7× 64 1.4× 13 0.4× 23 540
Nancy A. Schulte United States 12 486 1.4× 76 0.6× 281 3.2× 38 0.8× 69 1.9× 25 750

Countries citing papers authored by Sevil Zencir

Since Specialization
Citations

This map shows the geographic impact of Sevil Zencir's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Sevil Zencir with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Sevil Zencir more than expected).

Fields of papers citing papers by Sevil Zencir

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Sevil Zencir. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Sevil Zencir. The network helps show where Sevil Zencir may publish in the future.

Co-authorship network of co-authors of Sevil Zencir

This figure shows the co-authorship network connecting the top 25 collaborators of Sevil Zencir. A scholar is included among the top collaborators of Sevil Zencir based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Sevil Zencir. Sevil Zencir is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zencir, Sevil, Maria Jessica Bruzzone, Françoise Stutz, et al.. (2025). A two-step regulatory mechanism dynamically controls histone H3 acetylation by SAGA complex at growth-related promoters. Nucleic Acids Research. 53(7).
2.
Topçu, Zeki, et al.. (2024). Techno-ethical concerns related to genetic sequencing reports. Biosystems. 246. 105354–105354.
3.
Shore, David, Sevil Zencir, & Benjamin Albert. (2021). Transcriptional control of ribosome biogenesis in yeast: links to growth and stress signals. Biochemical Society Transactions. 49(4). 1589–1599. 46 indexed citations
4.
Zencir, Sevil, et al.. (2020). Mechanisms coordinating ribosomal protein gene transcription in response to stress. Nucleic Acids Research. 48(20). 11408–11420. 30 indexed citations
5.
Hacıoğlu, Sibel, et al.. (2020). Expression and DNA methylation profiles of EZH2-target genes in plasma exosomes and matched primary tumor tissues of the patients with diffuse large B-cell lymphoma. Clinical & Translational Oncology. 23(6). 1152–1166. 11 indexed citations
6.
7.
Vann, Kendra R., et al.. (2016). Inhibition of human DNA topoisomerase IIα by two novel ellipticine derivatives. Bioorganic & Medicinal Chemistry Letters. 26(7). 1809–1812. 32 indexed citations
8.
Caner, Vildan, Sibel Hacıoğlu, İsmail Sarı, et al.. (2015). MYD88 Expression and L265P Mutation in Mature B-Cell Non-Hodgkin Lymphomas. Genetic Testing and Molecular Biomarkers. 19(7). 372–378. 8 indexed citations
9.
Zencir, Sevil, et al.. (2015). Binding of Multiple Rap1 Proteins Stimulates Chromosome Breakage Induction during DNA Replication. PLoS Genetics. 11(8). e1005283–e1005283. 13 indexed citations
10.
Zencir, Sevil, Monimoy Banerjee, Melanie J. Dobson, et al.. (2013). New partner proteins containing novel internal recognition motif for human glutaminase interacting protein (hGIP). Biochemical and Biophysical Research Communications. 432(1). 10–15. 5 indexed citations
12.
Zencir, Sevil, Nehir Ünver Somer, Gülen İrem Kaya, et al.. (2012). The Effects of Arolycoricidine and Narciprimine on Tumor Cell Killing and Topoisomerase Activity. Records of Natural Products. 6(4). 381–385. 17 indexed citations
13.
Zencir, Sevil, et al.. (2011). Identification of brain-specific angiogenesis inhibitor 2 as an interaction partner of glutaminase interacting protein. Biochemical and Biophysical Research Communications. 411(4). 792–797. 20 indexed citations
14.
Caner, Vildan, et al.. (2010). The mRNA expression of cytochrome P450 isoforms in human gastric tissue.. PubMed. 57(98). 372–6. 5 indexed citations
15.
Baran, Yusuf, et al.. (2010). Imatinib-induced apoptosis: a possible link to topoisomerase enzyme inhibition. Journal of Clinical Pharmacy and Therapeutics. 36(6). 673–679. 6 indexed citations
16.
Çeti̇ner, Sali̇h, et al.. (2010). Oxidative Stress and Apoptosis in Relation to Exposure to Magnetic Field. Cell Biochemistry and Biophysics. 59(2). 71–77. 43 indexed citations
17.
Zencir, Sevil, et al.. (2008). Synthesis and biological activity evaluation of 1H-benzimidazoles via mammalian DNA topoisomerase I and cytostaticity assays. Clinical Cancer Research. 14. 2 indexed citations
18.
Caner, Vildan, et al.. (2008). No Strong Association Between HER-2/neu Protein Overexpression and Gene Amplification in High-grade Invasive Urothelial Carcinomas. Pathology & Oncology Research. 14(3). 261–266. 55 indexed citations
19.
Zencir, Sevil, et al.. (2008). Biological activity of bis-benzimidazole derivatives on DNA topoisomerase I and HeLa, MCF7 and A431 cells. Journal of Enzyme Inhibition and Medicinal Chemistry. 24(3). 844–849. 47 indexed citations
20.
Zencir, Sevil, et al.. (2008). Synthesis and biological activity evaluation of 1H-benzimidazoles via mammalian DNA topoisomerase I and cytostaticity assays. European Journal of Medicinal Chemistry. 44(5). 2280–2285. 49 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026